Work

Abstract CT098: Preliminary report of the TUMORIN Trial (using ex vivo tumoroids to predict immunotherapy response in NSCLC)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct098

Authors: Jared Ehrhar, Seth Currlin, Michelle Attaya, Jun Zhang, Rikhia Chakraborty

Institution: The University of Kansas Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822341

Cites:

Cited by:

Related to: 10